IDEAYA Biosciences, Inc. (IDYA) Total liabilities 2019–2025
IDEAYA Biosciences, Inc. (IDYA) total liabilities at each fiscal year-end, per SEC filings.
$86.4MFY2025 · since FY2019: $12.6M → $86.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $86.4M | +33.0% |
| FY2024 | $64.9M | +130.1% |
| FY2023 | $28.2M | -26.7% |
| FY2022 | $38.5M | -51.8% |
| FY2021 | $79.8M | -20.2% |
| FY2020 | $100.0M | +693.5% |
| FY2019 | $12.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More IDYA financial trends
IDYA RevenueIDYA Net incomeIDYA Net marginIDYA Gross profitIDYA Gross marginIDYA Operating incomeIDYA Operating marginIDYA Operating cash flowIDYA Free cash flowIDYA Capital expendituresIDYA Return on equityIDYA Stock buybacksIDYA Dividends paidIDYA Total assetsIDYA Shareholders’ equityIDYA overview →